Fortress Biotech, Inc. (FBIO) vs Gain Therapeutics, Inc. (GANX)
Fortress Biotech, Inc. and Gain Therapeutics, Inc. are both Biotechnology companies. Fortress Biotech, Inc. and Gain Therapeutics, Inc. are of similar size ($80.3M and $76.0M). Gain Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Fortress Biotech, Inc. trades at 0.7×. Gain Therapeutics, Inc. grew revenue faster over the last twelve months: 18.4% against 15.5%. Fortress Biotech, Inc. has the higher net margin (151.0% vs 0.00%) and the lower return on invested capital (−41.3% vs 0.00%). Across the 18 metrics below, Fortress Biotech, Inc. leads on 12 and Gain Therapeutics, Inc. on 6.
Valuation
Profitability
| Metric | FBIO | GANX | Biotechnology median |
|---|---|---|---|
| Gross margin | 65.59% | 0.00% | 65.16% |
| Operating margin | (42.61%) | 0.00% | 0.00% |
| Net margin | 150.98% | 0.00% | 0.00% |
| Free cash flow margin | 183.80% | 0.00% | 0.00% |
| Return on equity | 84.91% | (268.30%) | (57.72%) |
| Return on assets | 43.38% | (159.22%) | (49.22%) |
| Return on invested capital | (41.34%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack